Here is the latest stock price and chart of Aurobindo Pharma. For more details, see the Aurobindo Pharma company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.
Know More: Which way are the markets & the mutual fund industry headed?
Live BSE Quotes | Jan 25, 2021 (Close) | ||
---|---|---|---|
Price (Rs)998.00 | Open (Rs) 930.00 | High (Rs) 1,023.10 | Low (Rs) 930.00 |
% Change8.05 | Volume 526,031 | Value (Rs) 520,467,173 | 52-Week H/L 1,023.10 / 281.15 |
Live NSE Quotes | Jan 25, 2021 (Close) | ||
---|---|---|---|
Price (Rs)998.60 | Open (Rs) 935.00 | High (Rs) 1,023.70 | Low (Rs) 932.00 |
% Change8.10 | Volume 14,754,225 | Value (Rs) 14,733,569,085 | 52-Week H/L 1,023.70 / 288.85 |
Change | |||||
---|---|---|---|---|---|
1 Day 8.05% | 1 Month 9.92% | 3 Months 27.19% | 1 Year 95.30% | 5 Years (CAGR)* 4.06% | 10 Years (CAGR)* 23.01% |
* Compound Annual Growth Rate
Valuation | |||
---|---|---|---|
EPS (Rs)* 51.38 | P/E Ratio (x) 19.43 | Market Cap (Rs m) 583,998.66 | P/BV (x) 4.20 |
*Trailing 12 months earnings, excluding extraordinary / exceptional items. | BSE Sensex | CNX Nifty |
![]() |
||
S&P BSE SENSEX ![]() |
||||||
PERIOD |
AUROBINDO PHARMA last traded price had surged 8.1% to Rs 998.0 on the BSE. On the NSE, AUROBINDO PHARMA last traded price had surged 8.1% to Rs 998.6. The total volume of shares traded was 15.3 m.
Overall, the broader S&P BSE HEALTHCARE Index was up by 0.9%. And the benchmark S&P BSE SENSEX was at 48,347.6 (down 1.1%).
Over the last 30 days, the AUROBINDO PHARMA share price is up 16.5%. And over the last one year, AUROBINDO PHARMA share price is up 100.5%.
What else is happening in the markets today? Dig in...
Indian share markets witnessed huge selling pressure today and failed to hold on to their opening gains as profit booking and weakness across all sectors erased gains.
For the quarter ended June 2020, AUROBINDO PHARMA has posted a net profit of Rs 8 bn (up 25.6% YoY). Sales on the other hand came in at Rs 59 bn (up 8.8% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.
For the quarter ended March 2020, AUROBINDO PHARMA has posted a net profit of Rs 9 bn (up 48.2% YoY). Sales on the other hand came in at Rs 62 bn (up 16.4% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.
Here's an analysis of the annual report of AUROBINDO PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of AUROBINDO PHARMA. Also includes updates on the valuation of AUROBINDO PHARMA.
More Views on NewsIn this video, I'll show you why it might be the right time to take money of the table in pharma stocks.
The pandemic failed to thwart Richa's investing success formula for 2020.
In this video, I'll show you a crucial chart that you need to check before you decide to sell any stock or index.
Our ace stock picker is ready to capitalise on a big growth opportunity.
More